Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | TP53 | P04637 | 3/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 3/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.70 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.61 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.61 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29543568 | 1.00 | SMN1; SMN2 (0.73) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL9975322 | 0.95 | SMN1; SMN2 (0.67) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL5590272 | 0.93 | ALDH1A1 (0.64) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL5590400 | 0.93 | ALDH1A1 (0.64) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL9920519 | 0.91 | ALDH1A1 (0.61) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL23092286 | 0.89 | SMN1; SMN2 (0.70) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL17486128 | 0.89 | ALDH1A1 (0.59) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL15046261 | 0.89 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL22537957 | 0.89 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT | |
| SCHEMBL12551646 | 0.87 | ALDH1A1 (0.57) | SMN1; SMN2ALDH1A1TP53HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629639-B2 | Spacer for a spiral wound membrane | EVOVE LTD (GB) | 2026-05-19 | — | — | US | disclosed |
| EP-4722699-A1 | SAMPLE FOR CRYSTAL STRUCTURE ANALYSIS, SAMPLE PRECURSOR FOR CRYSTAL STRUCTURE ANALYSIS, METHOD FOR PRODUCING SAMPLE FOR CRYSTAL STRUCTURE ANALYSIS, AND SAMPLE PREPARATION KIT FOR CRYSTAL STRUCTURE ANALYSIS | The University of Tokyo (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12317743-B2 | N-type semiconductor, and organic photoelectric device, image sensor, and electronic device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-05-27 | — | — | US | disclosed |
| WO-2024248036-A1 | SAMPLE FOR CRYSTAL STRUCTURE ANALYSIS, SAMPLE PRECURSOR FOR CRYSTAL STRUCTURE ANALYSIS, METHOD FOR PRODUCING SAMPLE FOR CRYSTAL STRUCTURE ANALYSIS, AND SAMPLE PREPARATION KIT FOR CRYSTAL STRUCTURE ANALYSIS | 国立大学法人東京大学 | 2024-12-05 | — | — | WO | disclosed |
| EP-4397399-A2 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | G2O Water Technologies Limited (GB) | 2024-07-10 | — | — | EP | disclosed |
| US-20240157304-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | EVOVE LTD (GB) | 2024-05-16 | — | — | US | disclosed |
| US-20240149223-A1 | MEMBRANE DEVICE | EVOVE LTD (GB) | 2024-05-09 | — | — | US | disclosed |
| EP-4304765-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | Evove Ltd (GB) | 2024-01-17 | — | — | EP | disclosed |
| EP-4304766-A1 | MEMBRANE DEVICE | Evove Ltd (GB) | 2024-01-17 | — | — | EP | disclosed |
| US-11815475-B2 | Method for identifying molecular structure | THE UNIVERSITY OF TOKYO (JP) | 2023-11-14 | — | — | US | disclosed |
| US-20130146073-A1 | SPRAY AND/OR SOIL TREATMENT OF TOBACCO TO REDUCE TSNAs | PHILIP MORRIS USA INC. (US) | 2013-06-13 | — | — | US | disclosed |
| US-8353300-B2 | Sodium chloride spray treatment of soil surrounding tobacco plants to reduce TSNAs | PHILIP MORRIS USA INC. (US) | 2013-01-15 | — | — | US | disclosed |
| US-20080202538-A1 | SPRAY AND/OR SOIL TREATMENT OF TOBACCO TO REDUCE TSNAs | PHILIP MORRIS USA INC. (US) | 2008-08-28 | — | — | US | disclosed |
| WO-2008025941-A2 | COMPOUNDS FOR IMAGING AND THERAPY | ISIS INNOVATION LIMITED (GB) | 2008-03-06 | — | — | WO | disclosed |
| US-20070020519-A1 | Anode active material, manufacturing method thereof and lithium battery using the anode active material | SAMSUNG SDI CO., LTD. (KR) | 2007-01-25 | — | — | US | disclosed |
| US-20050034365-A1 | Spray and/or soil treatment of tobacco to reduce TSNAs | PHILIP MORRIS USA INC. | 2005-02-17 | — | — | US | disclosed |
| WO-2004068973-A2 | SPRAY AND/OR SOIL TREATMENT OF TOBACCO TO REDUCE TSNAS | PHILIP MORRIS PRODUCTS S.A. (CH) | 2004-08-19 | — | — | WO | disclosed |
| WO-2002014254-A1 | PROCESS FOR PRODUCING KETONE BY OXIDATIVE DECOMPOSITION OF OLEFIN | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2002-02-21 | — | — | WO | disclosed |
| JP-2002053516-A | METHOD OF PRODUCING KETONE BY OXIDATIVE DEGRADATION OF OLEFIN | JAPAN SCIENCE & TECHNOLOGY CORP | 2002-02-19 | — | — | JP | disclosed |
| US-5190870-A | Method for oxidizing hydrocarbons with a hydroxylase from a methane monooxygenase | AMOCO CORPORATION (US) | 1993-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629639-B2 | Spacer for a spiral wound membrane | AQP1, AQP3, AQP4 | SMN1; SMN2 3946/4885ALDH1A1 1090/4885TP53 1222/4885 |
| US-12317743-B2 | N-type semiconductor, and organic photoelectric device, image sensor, and electronic device including the same | NCS1, SCN1A, SCN1B | SMN1; SMN2 2241/4885ALDH1A1 1311/4885TP53 2377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.